Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis

BACKGROUND: The global death toll from coronavirus disease 2019 (COVID-19) has exceeded 2 million, and treatments to decrease mortality are needed urgently. OBJECTIVES: To examine the probabilities of a clinically meaningful reduction in mortality for remdesivir and systemic corticosteroids. DESIGN,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Todd C., McDonald, Emily G., Butler-Laporte, Guillaume, Harrison, Luke B., Cheng, Matthew P., Brophy, James M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849442/
https://www.ncbi.nlm.nih.gov/pubmed/33540128
http://dx.doi.org/10.1016/j.ijid.2021.01.065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849442/
https://www.ncbi.nlm.nih.gov/pubmed/33540128
http://dx.doi.org/10.1016/j.ijid.2021.01.065

Ejemplares similares